Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide-Reference-Cited by-同舟云学术

Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide

Published:2013-06-02 Issue:1 Volume:114 Page:111-116
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Reddy Krishna,Gaspar Laurie E.,Kavanagh Brian D.,Waziri Allen,Damek Denise M.,Ney Douglas,Lillehei Kevin O.,Chen Changhu

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Neurology,Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-013-1159-6.pdf

Reference12 articles.

1. Giovagnoli AR, Silvani A, Colombo E et al (2005) Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry 76:562–568

2. Li J, Bentzen SM, Renschler M et al (2008) Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis. Int J Radiat Oncol Biol Phys 71:64–70

3. Jakola AS, Gulati S, Weber C et al (2011) Postoperative deterioration in health related quality of life as predictor for survival in patients with glioblastoma: a prospective study. PLoS ONE 6(12):e28592

4. Henriksson R, Asklund T, Poulsen HS (2011) Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review. J Neurooncol 104:639–646

5. Reddy K, Damek D, Gaspar LE et al (2012) Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys 84(3):655–660

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDK7 and CDK9 inhibition interferes with transcription, translation, and stemness, and induces cytotoxicity in GBM irrespective of temozolomide sensitivity;Neuro-Oncology;2023-08-08

2. Radiotherapy for elderly patients with glioblastoma: an assessment of hypofractionation and modern treatment techniques;Chinese Clinical Oncology;2022-10

3. What we need to know about uncertainty in illness among people with primary malignant brain tumours: A mixed‐methods systematic review;Journal of Clinical Nursing;2022-09-07

4. Quality of life following concurrent temozolomide-based chemoradiation therapy or observation in low-grade glioma;Journal of Neuro-Oncology;2022-01-22